LUIS A NIDEA
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SOUTH BEND, IN NPI 1154311751
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology IN Regeneron Healthcare Solutions, Inc. All categories
General Payments — all program years on this page
$2,658.05
- Category: General Payments
- Program years: PY2018–2024
- Record count: 110
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $797.41 across 27 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $797.41 | 27 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $137.26 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $125.00 | 1 |
| Medtronic, Inc. | $103.51 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $94.63 | 4 |
| GENZYME CORPORATION | $65.58 | 3 |
| ABBVIE INC. | $37.04 | 2 |
| Janssen Biotech, Inc. | $33.47 | 2 |
| Ipsen Biopharmaceuticals, Inc | $31.00 | 1 |
| Madrigal Pharmaceuticals | $28.78 | 1 |
| Lilly USA, LLC | $25.32 | 1 |
| Ferring Pharmaceuticals Inc. | $21.42 | 1 |
| Gilead Sciences, Inc. | $21.19 | 1 |
| PFIZER INC. | $21.15 | 1 |
| Braintree Laboratories, Inc. | $18.92 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $18.02 | 1 |
| Celgene Corporation | $15.12 | 1 |
By program year
Records — PY2024 (27)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.